Top news of the week: 23.03.2022.
Companies And Industries
Three Biopharma Companies Heading to Nasdaq Through SPACs
California-based Apexigen and two other companies are planning to move to the Nasdaq Stock Exchange following their mergers with SPACs.
Ex-Biogen R&D head Sandrock takes the top job at Voyager
Voyager Therapeutics has lost little time in elevating Al Sandrock to the chief executive position, with the appointment
Biopharma deal volume up by 41%, while M&As are cut in half
As biopharma deal values climb, industry M&As are at a five-year low, not yet showing the pickup in 2022 that some analysts expected. BioWorld has recorded 330 deals, including ...
Money raised by biopharma: 2022 vs. 2021 vs. 2020 vs. 2019
Total raised in public, private and other financings of biopharma companies, comparing 2022 vs. 2021 vs. 2020 vs. 2019.
JHL's Judas Kiss: an Inside Look at JHL Biotech's Theft from Genentech
A closer look at legal action against executives from the company formerly known as JHL Biotech who recruited scientists from Genentech to steal trade secrets related to several cancer ...
U.S. and China Edge Toward Agreement on Audits Amidst Delisting Threats
U.S. and Chinese regulators are edging toward a cooperation plan on Chinese companies that have stock listed on U.S. stock exchanges.
Biomarkers: a Beacon of Hope for the Future of Alzheimer's
Esai, Biogen, Diadem and ProMis all presented their findings on biomarker research at this year's International Conference on Alzheimer's and Parkinson's Diseases.
2022 Luminaries
The HBA Luminary award was introduced in 2014 as part of the HBA’s 25th anniversary of the Woman of the Year (WOTY). This year, the HBA is proud to recognize 84 senior women, identified by ...